⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6433 | 1.00 | — | — | |
| SCHEMBL1183636 | 1.00 | — | — | |
| SCHEMBL7396758 | 1.00 | ALDH1A1 (0.62) | — | |
| Hydrochloric Acid SCHEMBL29448819 | 0.97 | ALDH1A1 (0.59) | — | |
| Hydrochloric Acid SCHEMBL2852111 | 0.97 | ALDH1A1 (0.59) | — | |
| SCHEMBL22750002 | 0.97 | ALDH1A1 (0.59) | — | |
| Hydrochloric Acid SCHEMBL158225 | 0.97 | ALDH1A1 (0.59) | — | |
| Ammonia Solution, Strong SCHEMBL28108684 | 0.97 | ALDH1A1 (0.59) | — | |
| Acetic Acid SCHEMBL28270661 | 0.94 | ALDH1A1 (0.56) | — | |
| Alanine SCHEMBL28074362 | 0.92 | ALDH1A1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3692 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025123055-A1 | NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND ASSOCIATED METHODS FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| WO-2025081231-A1 | INHIBITORS AND USES THEREFOR | Infensa Bioscience Pty Ltd (AU) | 2025-04-24 | — | — | WO | claimed |
| WO-2025054727-A1 | RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2025-03-20 | — | — | WO | claimed |
| EP-4499663-A1 | RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS | Provincial Health Services Authority (CA) | 2025-02-05 | — | — | EP | claimed |
| US-20240368232-A1 | ANTIVIRAL LARAZOTIDE DERIVATIVES | FASANO ALESSIO (US) | 2024-11-07 | — | — | US | claimed |
| US-20240158439-A1 | INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY | PROVID PHARMACEUTICALS INC. | 2024-05-16 | — | — | US | claimed |
| EP-4352074-A1 | ANTIVIRAL LARAZOTIDE DERIVATIVES | Fasano, Alessio (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117778530-A | Method for adding preset joint to 5' end of single-stranded DNA | 清华大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117551039-A | Aryl formamide compound, preparation method thereof and application of aryl formamide compound in resisting enterovirus EV71 | 武汉大学 | 2024-02-13 | — | — | CN | claimed |
| EP-4308585-A1 | INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II HLA-DRB1*15:01 MOLECULES WITH ENHANCED METABOLIC STABILITY | Provid Pharmaceuticals Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| EP-0927723-A1 | Bicyclic depsipeptides promoting the production of apolipoprotein E | Nisshin Flour Milling Co., Ltd. (JP) | 1999-07-07 | — | — | EP | claimed |
| EP-0606881-B1 | Cyclic pentapeptides having a beta-turn and a gamma-turn | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-05-12 | — | — | EP | claimed |
| EP-0827496-A1 | CATALIC ENANTIOSELECTIVE SYNTHESIS OF A SPIRO-FUSED AZETIDINONE | SCHERING CORPORATION (US) | 1998-03-11 | — | — | EP | claimed |
| US-5672583-A | Carboxy-peptidyl derivatives as antidegenerative active agents | MERCK & CO., INC. (US) | 1997-09-30 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| WO-1996027587-A1 | CATALIC ENANTIOSELECTIVE SYNTHESIS OF A SPIRO-FUSED AZETIDINONE | SCHERING CORPORATION (US) | 1996-09-12 | — | — | WO | claimed |
| EP-0671911-A4 | CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS. | MERCK & CO INC (US) | 1996-08-21 | — | — | EP | claimed |
| EP-0671911-A1 | CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO. INC. (US) | 1995-09-20 | — | — | EP | claimed |
| US-5403952-A | Substituted cyclic derivatives as novel antidegenerative agents | MERCK & CO., INC. (US) | 1995-04-04 | — | — | US | claimed |
| WO-1994012169-A1 | CARBOXY-PEPTIDYL DERIVATIVES AS ANTIDEGENERATIVE ACTIVE AGENTS | MERCK & CO., INC. (US) | 1994-06-09 | — | — | WO | claimed |